FDA法规事务代理副专员迈克尔 夏贝尔说：“该产品活性成分的安全性、有效性未向FDA提出。
The safety and effectiveness of the active ingredient in this product have not been demonstrated to the FDA.
具体结论如下：研究了超高压处理对副溶血性弧菌致死率、细胞超微结构、细胞膜通透性、细胞ATP酶活性的影响，为探讨微生物的高压致死机理提供依据。
The results were as followed. The effect of ultra high pressure treatment on the lethal rate, the ultra-structure, membrane permeability, ATPase activity of Vibio Parahaemolyticus were studied.
应用推荐